{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:46:53Z","timestamp":1785714413137,"version":"3.56.0"},"reference-count":50,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171099"],"award-info":[{"award-number":["82171099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000940"],"award-info":[{"award-number":["82000940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970835"],"award-info":[{"award-number":["81970835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800867"],"award-info":[{"award-number":["81800867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["20ZR1409500"],"award-info":[{"award-number":["20ZR1409500"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Oxidative stress plays an indispensable role in pathogenesis of Graves\u2019 orbitopathy (GO). Ferroptosis is a newly discovered form of cell death resulting from lipid peroxidation. Little is known about the role of ferroptosis in GO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to identify the divergent role of ferroptosis in the GO and control orbital fibroblasts (OFs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Orbital fat\/connective tissues and serum immunoglobulins (Igs) were collected from GO and control subjects. Cell viability and lipid peroxidation were measured to evaluate ferroptosis sensitivity. Pyruvate dehydrogenase kinase 2 (PDK2) level and oxygen consumption rate were quantified to assess glycolysis status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Primary OFs were cultured from orbital tissues. Ferroptosis was induced by cystine deprivation and\/or erastin treatment. The GO OFs possessed stronger resistance to ferroptosis than the control OFs. Selenium, a potential ferroptosis inhibitor, protected the control OFs from ferroptosis. Both transcriptomic and proteomic analyses indicated glycolytic shift in the GO OFs. Metabolic profiling, PDK2 quantification, and oxygen consumption assay confirmed enhanced glycolysis in the GO OFs. Inhibition of glycolysis by PDK2 knockdown and dichloroacetic acid (DCA) promoted ferroptosis sensitivity in the GO OFs. The ferroptosis-sensitizing effects of DCA were also observed when the GO OFs were treated with GO-Igs. IGF1R overexpression in the GO OFs contributed to glycolysis shift. IGF1R inhibitory antibodies facilitated ferroptosis induction in the GO OFs, but the effects were less remarkable under GO-Igs treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These study findings establish that glycolysis facilitates ferroptosis resistance in the GO OFs, providing insights into the therapeutic role of glycolysis for GO treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgac163","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T14:11:56Z","timestamp":1647612716000},"page":"1994-2003","source":"Crossref","is-referenced-by-count":26,"title":["Insights Into Ferroptosis: Targeting Glycolysis to Treat Graves\u2019 Orbitopathy"],"prefix":"10.1210","volume":"107","author":[{"given":"Ruiqi","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"},{"name":"Laboratory of Myopia, Chinese Academy of Medical Sciences , Shanghai 200031 , China"},{"name":"NHC Key Laboratory of Myopia, Fudan University , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"},{"name":"Laboratory of Myopia, Chinese Academy of Medical Sciences , Shanghai 200031 , China"},{"name":"NHC Key Laboratory of Myopia, Fudan University , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"},{"name":"Laboratory of Myopia, Chinese Academy of Medical Sciences , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"},{"name":"Laboratory of Myopia, Chinese Academy of Medical Sciences , Shanghai 200031 , China"},{"name":"NHC Key Laboratory of Myopia, Fudan University , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4005-2772","authenticated-orcid":false,"given":"Andrew R","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Neurosciences, University of Minnesota , Minneapolis, MN 55455 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4287-3497","authenticated-orcid":false,"given":"Jiang","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Fudan Eye & ENT Hospital , Shanghai 200031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"2","key":"2022061616024386000_CIT0001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol."},{"issue":"4","key":"2022061616024386000_CIT0002","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022061616024386000_CIT0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","article-title":"2021 update on thyroid-associated ophthalmopathy","volume":"45","author":"Neag","year":"2022","journal-title":"J Endocrinol Invest."},{"key":"2022061616024386000_CIT0004","doi-asserted-by":"crossref","first-page":"608733","DOI":"10.3389\/fendo.2020.608733","article-title":"Antioxidant therapy in Graves\u2019 orbitopathy","volume":"11","author":"Lanzolla","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"2022061616024386000_CIT0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40618-019-01116-4","article-title":"Immunohistochemical analysis of human orbital tissue in Graves\u2019 orbitopathy","volume":"43","author":"Hai","year":"2020","journal-title":"J Endocrinol Invest."},{"issue":"5","key":"2022061616024386000_CIT0006","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1210\/clinem\/dgab035","article-title":"Genetic profiling of orbital fibroblasts from patients with Graves\u2019 orbitopathy","volume":"106","author":"Rotondo Dottore","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2022061616024386000_CIT0007","first-page":"1566","article-title":"Histone deacetylase 4 controls extracellular matrix production in orbital fibroblasts from Graves\u2019 ophthalmopathy patients","volume":"31","author":"Ekronarongchai","year":"2021","journal-title":"Thyroid."},{"key":"2022061616024386000_CIT0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev Biochem."},{"issue":"4","key":"2022061616024386000_CIT0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1507\/endocrj.EJ19-0521","article-title":"Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves\u2019 orbitopathy","volume":"67","author":"Ko","year":"2020","journal-title":"Endocr J."},{"issue":"2","key":"2022061616024386000_CIT0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/IOP.0000000000001514","article-title":"The effect of smoking on mitochondrial biogenesis in patients with Graves ophthalmopathy","volume":"36","author":"Yuksel","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg."},{"issue":"13","key":"2022061616024386000_CIT0011","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1167\/iovs.19-27376","article-title":"Therapeutic effect of Curcumin, a plant polyphenol extracted from Curcuma longae, in fibroblasts from patients with Graves\u2019 orbitopathy","volume":"60","author":"Lee","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"2022061616024386000_CIT0012","doi-asserted-by":"crossref","first-page":"108894","DOI":"10.1016\/j.cbi.2019.108894","article-title":"Polydatin attenuates orbital oxidative stress in Graves\u2019 orbitopathy through the NRF2 pathway","volume":"315","author":"Li","year":"2020","journal-title":"Chem Biol Interact."},{"issue":"6","key":"2022061616024386000_CIT0013","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","article-title":"Redox regulation of immunometabolism","volume":"21","author":"Muri","year":"2021","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"2022061616024386000_CIT0014","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","article-title":"Role of mitochondria in ferroptosis","volume":"73","author":"Gao","year":"2019","journal-title":"Mol Cell."},{"key":"2022061616024386000_CIT0015","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The role of erastin in ferroptosis and its prospects in cancer therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"4","key":"2022061616024386000_CIT0016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/JME-20-0143","article-title":"PDK2-enhanced glycolysis promotes fibroblast proliferation in thyroid-associated ophthalmopathy","volume":"65","author":"Ma","year":"2020","journal-title":"J Mol Endocrinol."},{"key":"2022061616024386000_CIT0017","doi-asserted-by":"crossref","first-page":"9210572","DOI":"10.1155\/2020\/9210572","article-title":"Selenium supplementation may decrease thyroid peroxidase antibody titer via reducing oxidative stress in euthyroid patients with autoimmune thyroiditis","volume":"2020","author":"Tian","year":"2020","journal-title":"Int J Endocrinol."},{"issue":"1","key":"2022061616024386000_CIT0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000494837","article-title":"A 2018 European Thyroid Association survey on the use of selenium supplementation in Graves\u2019 hyperthyroidism and Graves\u2019 orbitopathy","volume":"8","author":"Negro","year":"2019","journal-title":"Eur Thyroid J."},{"issue":"1","key":"2022061616024386000_CIT0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s42000-019-00133-5","article-title":"Challenges and perspectives of selenium supplementation in Graves\u2019 disease and orbitopathy","volume":"19","author":"Bednarczuk","year":"2020","journal-title":"Hormones (Athens)."},{"issue":"20","key":"2022061616024386000_CIT0020","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med."},{"issue":"4","key":"2022061616024386000_CIT0021","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med."},{"issue":"2","key":"2022061616024386000_CIT0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ceo.13899","article-title":"Thyroid eye disease: redefining its management-a review","volume":"49","author":"Jain","year":"2021","journal-title":"Clin Exp Ophthalmol."},{"issue":"2","key":"2022061616024386000_CIT0023","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cells10020383","article-title":"Lessons learned from targeting IGF-I receptor in thyroid-associated ophthalmopathy","volume":"10","author":"Janssen","year":"2021","journal-title":"Cells"},{"issue":"6","key":"2022061616024386000_CIT0024","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2022061616024386000_CIT0025","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1167\/iovs.18-26268","article-title":"PH20 inhibits TGF\u03b21-induced differentiation of perimysial orbital fibroblasts via hyaluronan-CD44 pathway in thyroid-associated ophthalmopathy","volume":"60","author":"Ma","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"6","key":"2022061616024386000_CIT0026","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2022061616024386000_CIT0027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free Radic Biol Med."},{"issue":"4","key":"2022061616024386000_CIT0028","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"6","key":"2022061616024386000_CIT0029","doi-asserted-by":"crossref","first-page":"e20210518","DOI":"10.1084\/jem.20210518","article-title":"Ferroptosis in infection, inflammation, and immunity","volume":"218","author":"Chen","year":"2021","journal-title":"J Exp Med."},{"issue":"5","key":"2022061616024386000_CIT0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"6","key":"2022061616024386000_CIT0031","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"2022061616024386000_CIT0032","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biol Dis Cell."},{"issue":"1-2","key":"2022061616024386000_CIT0033","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell."},{"issue":"2","key":"2022061616024386000_CIT0034","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"2","key":"2022061616024386000_CIT0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in hypoxia-inducible factor biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metab."},{"key":"2022061616024386000_CIT0036","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol."},{"issue":"10","key":"2022061616024386000_CIT0037","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s00417-021-05339-1","article-title":"18 F-FDG-PET\/MRI in patients with Graves\u2019 orbitopathy","volume":"259","author":"Weber","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"5","key":"2022061616024386000_CIT0038","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cbf.3632","article-title":"Proteomic analysis of thyroid tissue reveals enhanced catabolic activity in Graves\u2019 disease compared to toxic multinodular goitre","volume":"39","author":"Temiz Karadag","year":"2021","journal-title":"Cell Biochem Funct"},{"issue":"8","key":"2022061616024386000_CIT0039","doi-asserted-by":"crossref","first-page":"e2866","DOI":"10.1210\/clinem\/dgab256","article-title":"LncRNA LPAL2\/miR-1287-5p\/EGFR axis modulates TED-derived orbital fibroblast activation through cell adhesion factors","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022061616024386000_CIT0040","doi-asserted-by":"crossref","first-page":"bqab188","DOI":"10.1210\/endocr\/bqab188","article-title":"The role of mitochondria-linked fatty-acid uptake-driven adipogenesis in Graves orbitopathy","volume":"162","author":"Zhang","year":"2021","journal-title":"Endocrinology."},{"issue":"8","key":"2022061616024386000_CIT0041","doi-asserted-by":"crossref","first-page":"e3125","DOI":"10.1210\/clinem\/dgab154","article-title":"IL-38 exerts anti-inflammatory and antifibrotic effects in thyroid-associated ophthalmopathy","volume":"106","author":"Shi","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2022061616024386000_CIT0042","doi-asserted-by":"crossref","first-page":"653627","DOI":"10.3389\/fendo.2021.653627","article-title":"Insulin-like growth factor pathway and the thyroid","volume":"12","author":"Smith","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"2022061616024386000_CIT0043","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/en.2019-00055","article-title":"Arrestin-\u03b2-1 Physically scaffolds TSH and IGF1 receptors to enable crosstalk","volume":"160","author":"Krieger","year":"2019","journal-title":"Endocrinology."},{"issue":"5","key":"2022061616024386000_CIT0044","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022061616024386000_CIT0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000511538","article-title":"Targeting TSH and IGF-1 receptors to treat thyroid eye disease","volume":"9","author":"Neumann","year":"2020","journal-title":"Eur Thyroid J."},{"issue":"5","key":"2022061616024386000_CIT0046","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0089","article-title":"Evidence that Graves\u2019 ophthalmopathy immunoglobulins do not directly activate IGF-1 receptors","volume":"28","author":"Marcus-Samuels","year":"2018","journal-title":"Thyroid."},{"key":"2022061616024386000_CIT0047","doi-asserted-by":"crossref","first-page":"608428","DOI":"10.3389\/fendo.2020.608428","article-title":"Selenium in the treatment of Graves\u2019 hyperthyroidism and eye disease","volume":"11","author":"Lanzolla","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"11","key":"2022061616024386000_CIT0048","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1210\/jc.2017-01736","article-title":"Double-blind, placebo-controlled, randomized trial of selenium in Graves hyperthyroidism","volume":"102","author":"Kahaly","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022061616024386000_CIT0049","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1055\/a-0658-7889","article-title":"Mechanistic pathways of selenium in the treatment of Graves\u2019 disease and Graves\u2019 orbitopathy","volume":"50","author":"Marin\u00f2","year":"2018","journal-title":"Horm Metab Res."},{"issue":"5","key":"2022061616024386000_CIT0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/IOP.0000000000001931","article-title":"Anti-inflammatory and antioxidant effects of selenium on orbital fibroblasts of patients with Graves ophthalmopathy","volume":"37","author":"Kim","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac163\/43370330\/dgac163.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/1994\/44110603\/dgac163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/7\/1994\/44110603\/dgac163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T12:09:07Z","timestamp":1655381347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/7\/1994\/6550655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,3,18]]},"published-print":{"date-parts":[[2022,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac163","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741858630.793593761","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,3,18]]}}}